Canada markets closed

Vaxil Bio Ltd. (VXL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.01000.0000 (0.00%)
At close: 03:31PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 1.37M
Enterprise Value 431.79k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.54
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.84

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-50.00%
S&P500 52-Week Change 326.16%
52 Week High 30.0350
52 Week Low 30.0050
50-Day Moving Average 30.0125
200-Day Moving Average 30.0157

Share Statistics

Avg Vol (3 month) 385.43k
Avg Vol (10 day) 3154.53k
Shares Outstanding 5136.98M
Implied Shares Outstanding 6136.98M
Float 8N/A
% Held by Insiders 18.16%
% Held by Institutions 10.02%
Shares Short (Apr 30, 2024) 43.01k
Short Ratio (Apr 30, 2024) 40.07
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.00%
Shares Short (prior month Mar 28, 2024) 415.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Mar 10, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-12.61%
Return on Equity (ttm)-25.06%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -252k
Net Income Avi to Common (ttm)-254k
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)938k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.48
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-561k
Levered Free Cash Flow (ttm)-465.75k